XML 22 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:        
Net loss $ (849,000) $ (746,000)   $ (1,848,000)
Adjustments to reconcile net loss to net cash used by operating activities:        
Depreciation and amortization 280,000 278,000 $ 1,113,000 1,113,000
Deferred tax benefit       (1,395,000)
Impairment of other investments      
Decrease (increase) in assets:        
Prepaid expenses and other current assets (79,000) (37,000)   (8,000)
Deferred Tax benefit      
Impairment of other investment      
Increase (decrease) in liabilities:        
Accounts payable (353,000) (60,000)   106,000
Accrued expenses (13,000) 32,000   5,000
Net cash used by operating activities (1,014,000) (533,000)   (2,027,000)
Cash flows from investing activities:        
Purchase of property, plant and equipment (5,000)  
Purchase of investment (12,000)   (4,185,000)
Note receivable investment, net 1,000 (93,000)   (5,278,000)
Net cash used by investing activities (4,000) (105,000)   (9,463,000)
Cash flows from financing activities:        
Borrowings from note payable, related party 1,017,000 625,000   11,464,000
Net cash provided by financing activities 1,017,000 625,000   11,464,000
Net decrease in cash (1,000) (13,000)   (27,000)
Cash and cash equivalents at beginning of period 2,000 46,000 46,000 72,000
Cash and cash equivalents at end of period 1,000 33,000 2,000 46,000
Previously Reported [Member]        
Cash flows from operating activities:        
Net loss     (7,255,000) (1,848,000)
Adjustments to reconcile net loss to net cash used by operating activities:        
Depreciation and amortization     1,113,000  
Deferred tax benefit     (621,000)  
Impairment of other investments     4,100,000  
Decrease (increase) in assets:        
Prepaid expenses and other current assets     (60,000)  
Increase (decrease) in liabilities:        
Accounts payable     424,000  
Accrued expenses     57,000  
Net cash used by operating activities     (2,242,000)  
Cash flows from investing activities:        
Purchase of property, plant and equipment     (276,000)  
Purchase of investment     (65,000)  
Note receivable investment, net     (8,000)  
Net cash used by investing activities     (349,000)  
Cash flows from financing activities:        
Borrowings from note payable, related party     2,547,000  
Net cash provided by financing activities     2,547,000  
Net decrease in cash     (44,000)  
Cash and cash equivalents at beginning of period $ 2,000 $ 46,000 46,000  
Cash and cash equivalents at end of period     $ 2,000 $ 46,000